Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
about
Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccineMice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infectionTransmission of pathogens by Stomoxys flies (Diptera, Muscidae): a reviewThe soluble form of the EIAV receptor encoded by an alternative splicing variant inhibits EIAV infection of target cellsStructural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAVStructural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen AllelesHIV-1 Vaccine Trials: Evolving Concepts and DesignsA comparative analysis of viral matrix proteins using disorder predictors.Evaluation of six serological ELISA kits available in Italy as screening tests for equine infectious anaemia surveillanceEIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophagesBroader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine.Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45.A unique evolution of the s2 gene of equine infectious anemia virus in hosts correlated with particular infection statuses.Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.The inside out of lentiviral vectorsEnvelope determinants of equine lentiviral vaccine protection.Infection of equine monocyte-derived macrophages with an attenuated equine infectious anemia virus (EIAV) strain induces a strong resistance to the infection by a virulent EIAV strain.Cloning, expression and preliminary crystallographic analysis of the equine infectious anaemia virus (EIAV) gp45 ectodomain.The risk of introduction of equine infectious anemia virus into USA via cloned horse embryos imported from Canada.Characterization of Equine Infectious Anemia Virus Integration in the Horse GenomeThe Frequency of Cytidine Editing of Viral DNA Is Differentially Influenced by Vpx and Nucleosides during HIV-1 or SIVMAC Infection of Dendritic Cells.Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.Equine Infectious Anemia Virus Gag Assembly and Export Are Directed by Matrix Protein through trans-Golgi Networks and Cellular Vesicles.An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.Comprehensive analysis of the overall codon usage patterns in equine infectious anemia virus.Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain.Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.Dynamics of ESCRT proteins.Proteomic alteration of equine monocyte-derived macrophages infected with equine infectious anemia virus.Double-stranded-RNA-specific adenosine deaminase 1 (ADAR1) is proposed to contribute to the adaptation of equine infectious anemia virus from horses to donkeys.Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies.Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.Characterization of isolates of equine infectious anemia virus in Brazil.Validation according to OIE criteria of a monoclonal, recombinant p26-based, serologic competitive enzyme-linked immunosorbent assay as screening method in surveillance programs for the detection of Equine infectious anemia virus antibodies.Antibody escape kinetics of equine infectious anemia virus infection of horses.High genetic diversity of equine infectious anaemia virus strains from Slovenia revealed upon phylogenetic analysis of the p15 gag gene region.Detection and molecular characterization of equine infectious anemia virus in Mongolian horses.
P2860
Q21131325-2F3BE169-80C0-4A18-8E78-6F5F0D6DE803Q21146658-692C26A4-02B9-4297-9B33-3CB45A27E8C2Q24629673-AEF2C073-5AC9-4234-B78E-151873EA0DACQ27302868-19DB9920-EB04-461B-B377-0CEFC749EC31Q27652984-B46BB2F3-3052-4B92-AEB7-47206741E142Q27703610-73CDBCDF-68A1-4C7E-8521-D6701B12D32AQ30425520-B67286CF-825C-46E8-A212-B494DECD7693Q33378970-848C48AA-DF50-4E35-B2EE-6E675CF2DAAEQ33564571-B40E5CF0-B897-4B10-8F91-0FF7445C8784Q33620921-5141894F-BB8D-4EFF-84DD-752335AA9F59Q34133986-A59BA80C-0413-49CA-B84B-46A8152FAFD2Q34485027-A7CD5191-46F3-4022-A1F1-D1105B48C57EQ34580807-3D97E6FD-D900-45F1-A314-056C7A0E71F8Q34593906-5D8C639A-EAA2-471B-8F0B-C15718992676Q34633466-5F0BF291-5B2F-4773-8958-C2DD18C2F7DDQ34778836-BA17E61C-2659-45B1-BF37-620EF7080646Q34812619-7FF288D0-1E02-41EB-9267-B1E0B370E4AEQ34823864-1D6320A7-6A21-49E4-A642-29357D924A2FQ35649170-9E2ABF89-4870-42D6-A865-9B4EC12C0377Q35808693-0B89B9CD-F6EC-4A73-B95C-12DA378A651AQ35819276-D0416FFF-7AE9-4FDC-85D4-5DE68A8A262BQ35826784-681BC658-79A1-4631-9001-5A3D4D01C0ACQ36328526-55C6508A-1268-46B4-B9EC-3A119B2C6431Q36524040-82018E86-9665-4F7E-B262-9035670776D7Q37405780-1A5F6146-5BF8-430F-9797-645B56774FDAQ37425748-DE544503-EBB7-4992-9300-5D8DC1037D63Q37547504-B2211191-221E-4C70-BF81-B713D3FF033DQ37720380-2046165C-8666-4320-8DFC-75CAD4555BD5Q37950254-3F4E1018-1218-40B3-A08B-44CCB4681FAAQ38016323-AD46B1AF-757C-4AFF-A6A0-438B10A3CD9DQ38466790-709C8760-05F3-43BC-BB6B-81F919E18ABFQ39509941-E3D98C4F-AAED-400F-8F4F-FDCFE635D0DBQ39848883-11D3D594-014E-490F-9BC3-2D9CBD8878CFQ40079735-F529A1F1-7682-499E-8CCA-37DE9C281735Q40121209-EF40B59E-9C7B-4C78-BE0B-A5A84F59B14BQ40431779-1BEA13D3-2D98-48CF-8B62-CC6B070ABDAFQ40760045-A5D95FF8-C033-490D-8E37-82A8F5542329Q41067152-7844DEFD-3025-4E51-B99D-0300CD12E9E2Q41583839-3C6DB6B4-63C0-4755-BCA4-351DDBC734BBQ41918708-B47E386A-A401-4C2A-831B-FEC18C77EBE1
P2860
Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
@ast
Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
@en
type
label
Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
@ast
Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
@en
prefLabel
Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
@ast
Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
@en
P356
P1433
P1476
Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
@en
P2093
Jean-Luc Cadoré
Ronald C Montelaro
P304
P356
10.1051/VETRES:2004020
P577
2004-07-01T00:00:00Z